Since B-ALL represents 85% of acute lymphoblastic leukemia cases, determining the levels of HMMR mRNA and protein expression in bone marrow and peripheral blood samples from children with B-ALL is important. Here, HMMR is linked to precursor B-cell acute lymphoblastic leukemia.